Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact email@example.com
STOCKHOLM, March 5, 2018 /PRNewswire/ --
Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) – the Nomination Committee of Biotage AB announces its proposal for the election of the Board of Directors and Chairman of the Board for the forthcoming Annual General Meeting ("AGM").
The Nomination Committee proposes:
The other proposals from the Nomination Committee will be published in the Notices for the AGM.
The Nomination Committee for the AGM 2018 consists of Harald Høegh, Chairman, Vind AS, Marianne Flink, Swedbank Robur fonder, Thomas Ehlin, Fjärde AP-fonden and Ove Mattsson, Chairman of the Board.
The AGM will be held on Thursday 26 April 2018 in Uppsala.
This information was submitted for publication, through the agency of the contact persons set out above, at 08:30 CET on March 5, 2018.
Biotage offers efficient separation technologies from analysis to industrial-scale and high-quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage's products are used by public authorities, academic institutions, contract research and contract manufacturing organizations and in the pharmaceutical and food industries, among others. The company is headquartered in Uppsala and has offices in the US, UK, China, Japan, South Korea and India. Biotage has approx. 390 employees and had sales of 748 MSEK in 2017. Biotage is listed on Nasdaq Stockholm. Website: www.biotage.com
For further information:
Chairman of the Nomination Committee
Harald Høegh +47 22 12 28 00
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Press release (PDF)
©2017 PR Newswire. All Rights Reserved.